Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Watchman21on Mar 06, 2021 6:54pm
244 Views
Post# 32737303

Accessing $160B Cares Act Funding For Schools

Accessing $160B Cares Act Funding For Schools

Biden’s 1.9 T Covid19 Stimulus Bill

 

Just 0.1% (a tenth of a percentage) of the school ($160B) and testing ($50B) is $210m which sets us at a $1b valuation on a 5x revenue.  That’s $4-5share.  LA and NYC school districts are the 2 largest with 5000 schools.  Those two alone could eat millions of tests per week. Over 120k public, private and charter schools.  

 

DOE Educational Stabilization Funds (ESF) flows to each State Department of Education and K-12 schools tap into ESSER FUNDS 

 

K-12 CARES ACT FUNDING / ESSER Elementary & Secondary School Emergency Relief Funds 

 

TOTAL ESSER FUNDS

https://www.future-ed.org/what-congressional-covid-funding-means-for-k-12-schools/

 

ESSER SPECIFICS - Dept of Education

https://oese.ed.gov/offices/education-stabilization-fund/elementary-secondary-school-emergency-relief-fund/

 

CARES ACT FUNDING PER STATE

https://covid-relief-data.ed.gov

 

LIST OF STATE ESSER APPLICATIONS 

https://www.ncsl.org/ncsl-in-dc/standing-committees/education/cares-act-elementary-and-secondary-school-emergency-relief-fund-tracker.aspx

<< Previous
Bullboard Posts
Next >>